News Focus
News Focus
icon url

Bright Boy

05/28/22 11:12 AM

#479482 RE: jon_k84 #479477

Very astute comments!!!
icon url

Margin Buu

05/28/22 11:27 AM

#479487 RE: jon_k84 #479477

Very true, well said.
icon url

Realcool11

05/28/22 11:53 AM

#479494 RE: jon_k84 #479477

You’d think big pharma has qualified researchers that already see value in this, even if Walk Street doesn’t.
icon url

Maverick0408

05/28/22 12:09 PM

#479503 RE: jon_k84 #479477

This below statement from Dr. Toms is significant. They can bitch all they want! Personally I don’t think we should create negative spin against Novocure in social media and stuff. They are approved for a reason. Although the compliance is challenging and not ideal, patients and their consulting physicians ought to make the final call on what’s the best course of treatment. DCVAX-L certainly has a huge advantage here!

“IDHwt GBMs do not live more than 5 years other than those treated with DCVax or TTF. I have patients 5+ year survival treated on both protocols. I have zero long term survivors in 25 years of practice without. Do the math. The p value is highly significant”.